**Core Concept**
Alpha1 antitrypsin deficiency is a genetic disorder characterized by the deficiency of alpha1 antitrypsin (A1AT), a serine protease inhibitor that protects the lungs from elastase activity. This deficiency increases the risk of developing chronic obstructive pulmonary disease (COPD) and emphysema, especially in young individuals.

**Why the Correct Answer is Right**
High-resolution computed tomography (HRCT) is the preferred imaging modality for evaluating the lungs in patients with suspected alpha1 antitrypsin deficiency. HRCT can accurately detect early changes in lung morphology, such as bullae, honeycombing, and panacinar emphysema, which are characteristic of A1AT deficiency. These changes are often subtle and may not be apparent on conventional chest radiographs or other imaging modalities.

**Why Each Wrong Option is Incorrect**
* **Option A:** Chest X-ray is not sensitive enough to detect early changes in lung morphology associated with alpha1 antitrypsin deficiency.
* **Option B:** Magnetic resonance imaging (MRI) is not the preferred modality for evaluating lung parenchyma and is not typically used for diagnosing alpha1 antitrypsin deficiency.
* **Option D:** Lung function tests, such as spirometry and diffusion capacity, are useful for assessing the functional impact of alpha1 antitrypsin deficiency but are not the primary modality for evaluating lung morphology.

**Clinical Pearl / High-Yield Fact**
In patients with suspected alpha1 antitrypsin deficiency, HRCT should be performed as soon as possible to identify early changes in lung morphology and guide management.

**Correct Answer:** C. High-resolution computed tomography.